| Formulary Chapter 5: Infections - Full Chapter
|
|
| Chapter Links... |
 NICE NG199: Clostridioides difficile infection: antimicrobial prescribing |
| NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use |
| NICE NG79: Sinusitis (acute): antimicrobial prescribing |
| NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary) |
 Summary of antimicrobial prescribing guidance - managing common infections |
| Details... |
| 05.03.01 |
HIV infection |
|
|
| 05.03.01 |
Nucleoside reverse transcriptase inhibitors |
|
|
Abacavir
(Tablets)
|
Formulary
|
|
|
|
Abacavir and Lamivudine
|
Formulary
|
|
|
|
Abacavir with dolutegravir and lamivudine (Triumeq ®)
(Tablets)
|
Formulary
|
|
|
|
Efavirenz with emtricitabine and tenofovir disoproxil
|
Formulary
|
|
|
|
Elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide (Genvoya®)
|
Formulary
|
|
|
|
Emtricitabine (Emtriva®)
(Oral presentations)
|
Formulary
|
|
|
|
Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg (Eviplera®)
|
Formulary
|
Blueteq /prior approval form
|
|
|
Emtricitabine with rilpivirine and tenofovir alafenamide ( Odefsey® )
|
Formulary
|
|
|
|
Emtricitabine with tenofovir alafenamide (Descovy®)
|
Formulary
|
|
|
|
Emtricitabine with tenofovir disoproxil
|
Formulary
|
|
|
|
Lamivudine
|
Formulary
|
|
|
|
Lamivudine (Epivir®, Zeffix®)
|
Formulary
|
|
|
|
Lamivudine with dolutegravir (Dovato®)
(Oral )
|
Formulary
|
|
|
|
Lamivudine with tenofovir disoproxil and doravirine (Delstrigo®)
(Oral )
|
Formulary
|
|
|
|
Rilpivirine hydrochloride (Edurant®)
(tablets)
|
Formulary
|
|
|
|
Rilpivirine hydrochloride (Rekambys®)
(IV)
|
Formulary
|
|
|
|
Tenofovir, cobicistat, elvitegravir & emtricitabine (Stribild®)
|
Formulary
|
|
|
|
Zidovudine
(capsules )
|
Formulary
|
|
|
|
Zidovudine (Retrovir®)
(IV & SF solution)
|
Formulary
|
|
|
|
Zidovudine and Lamivudine
(tablets)
|
Formulary
|
|
|
|
| 05.03.01 |
Protease inhibitors |
|
|
Atazanavir
(capsules)
|
Formulary
|
|
|
|
Atazanavir with cobicistat (Evotaz®)
|
Formulary
|
Blueteq /prior approval form
|
|
|
Baloxavir marboxil
(Tablets)
|
Formulary
|
|
|
|
Bictegravir with emtricitabine and tenofovir alafenamide (Biktarvy®)
|
Formulary
|
|
|
|
Darunavir
|
Formulary
|
|
|
|
Darunavir with cobicistat (Rezolsta®)
|
Formulary
|
Blueteq /prior approval form
|
|
|
Darunavir with cobicistat, emtricitabine and tenofovir alafenamide (Symtuza®)
|
Formulary
|
Blueteq /prior approval form
|
|
|
Dolutegravir (Tivicay ®)
|
Formulary
|
|
|
|
Dolutegravir with rilpivirine (Juluca®)
|
Formulary
|
|
|
|
Fosamprenavir (Telzir®)
(tablets)
|
Formulary
|
|
|
|
Lopinavir and Ritonavir (Kaletra®)
(tablets & solution)
|
Formulary
|
|
|
|
Lopinavir with Ritonavir
(Oral )
|
Formulary
|
|
|
|
Nirmatrelvir With Ritonavir
|
Formulary
|
|
|
|
Ritonavir
(Oral presentations)
|
Formulary
|
|
|
|
| 05.03.01 |
Non-nucleoside reverse transcriptase inhibitors |
|
|
Doravirine (Pifeltro®)
|
Formulary
|
|
|
|
Etravirine (Intelence®)
(tablets)
|
Formulary
|
|
|
|
Nevirapine
|
Formulary
|
|
|
|
Nevirapine (Viramune®)
(tablets, extended release tablets & suspension)
|
Formulary
|
|
|
|
| 05.03.01 |
Other antiretrovirals |
|
|
Cabotegravir (Vocabria®)
|
Formulary
|
In line with NICE
|
NICE TA757: Cabotegravir with rilpivirine for treating HIV-1
|
Elbasvir with grazoprevir (Zepatier®)
|
Formulary
|
|
|
|
Enfuvirtide (Fuzeon®)
|
Formulary
|
|
|
|
Maraviroc
(tablets)
|
Formulary
|
|
|
|
Maraviroc (Celsentri®)
(tablets)
|
Formulary
|
|
|
|
Raltegravir (Isentress ®)
(tablets)
|
Formulary
|
|
|
|
| 05.03.01 |
Pharmacokinetic enhancers of antiretrovirals |
|
|
Cobicistat (Tybost ®)
|
Formulary
|
|
|
|
| 05.03.01 |
Combination Products |
|
|
| .... |
| Non Formulary Items |
Abacavir (Ziagen®)
|
Non Formulary
|
|
|
|
Abacavir and Lamivudine (Kivexa®)
(tablets)
|
Non Formulary
|
|
|
|
Abacavir and Lamivudine and Zidovudine (Trizivir®)
|
Non Formulary
|
|
|
|
Amprenavir (Agenerase®)
|
Non Formulary
|
|
|
|
Darunavir (Prezista®)
(tablets)
|
Non Formulary
|
|
|
|
Didanosine (Videx®)
(capsules)
|
Non Formulary
|
|
|
|
Efavirenz
(Tablets)
|
Non Formulary
|
|
|
|
Efavirenz with emtricitabine and tenofovir disoproxil (Atripla® )
|
Non Formulary
|
|
|
|
Emtricitabine with tenofovir disoproxil (Ictastan®)
|
Non Formulary
|
|
|
|
Emtricitabine with tenofovir disoproxil (Truvada®)
|
Non Formulary
|
|
|
|
Fostemsavir (Rukobia®)
|
Non Formulary
|
|
|
|
Indinavir (Crixivan®)
|
Non Formulary
|
|
|
|
Nelfinavir
|
Non Formulary
|
|
|
|
Ritonavir (Norvir®)
(tablets & SF solution)
|
Non Formulary
|
|
|
|
Saquinavir (Invirase®)
(tablets)
|
Non Formulary
|
|
|
|
Stavudine
(capsules)
|
Non Formulary
|
|
|
|
Tenofovir Disproxil (Viread®)
(tablets)
|
Non Formulary
|
|
NICE CG165: Hepatitis B (chronic) - diagnosis and management
NICE TA173: Hepatitis B (chronic) - tenofovir disoproxil
|
Tipranavir (Aptivus®)
|
Non Formulary
|
|
|
|
Zidovudine (Retrovir®)
(capsules )
|
Non Formulary
|
|
|
|
Zidovudine and Lamivudine (Combivir®)
(tablets)
|
Non Formulary
|
|
|
|
| |
Key |
 |
Restricted Drug |
 |
Unlicensed |
|
|
Link to adult BNF
|
|
|
Link to children's BNF
|
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
|
